Evidence map›Paper›PMID 30746254›Full record

ArticleJournal of thoracic disease2018

A pilot study of blood microRNAs and lung function in young healthy adults with fine particulate matter exposure.

Tianyu Zhou, Qing Yu, Chao Sun, Yunxia Wang, Yijue Zhong, Guangfa Wang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Particulate matter-induced epigenetic modifications and lung complications.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  3. The Effects and Pathogenesis of PM2.5 and Its Components on Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2023
    Review
  4. Airway hyperresponsiveness development and the toxicity of PM2.5.Environmental science and pollution research international · 2021
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tianyu ZhouDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing100034, China.
Qing YuDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing100034, China.
Chao SunDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing100034, China.
Yunxia WangDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing100034, China.
Yijue ZhongDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing100034, China.
Guangfa WangDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing100034, China.
Peking University First Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fine particulate exposure (PM

Indexed as

chronic obstructive pulmonary disease (COPD)epigeneticsFine particulate matter (PM2.5)lung function declinemicroRNA (miRNA)

Identifiers

PMID30746254
PMCPMC6344747
OpenAlexW2905198534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.